What is Nutrisense?
Nutrisense operates at the intersection of biotechnology and consumer wellness, providing a sophisticated CGM program that empowers users to monitor the physiological impact of diet, exercise, and sleep on blood glucose levels. By integrating real-time sensor data with professional guidance from registered dietitians, the company offers a comprehensive accountability framework for metabolic optimization. This approach addresses the increasing demand for preventative health tools that move beyond generic wellness advice, offering instead a granular, evidence-based understanding of individual metabolic responses. The company's market position is bolstered by its ability to translate complex biometric data into actionable lifestyle modifications, effectively bridging the gap between clinical-grade monitoring and daily health management.
How much funding has Nutrisense raised?
Nutrisense has raised a total of $25.1M across 2 funding rounds:
Debt
$73K
Series A
$25M
Debt (2021): $73K with participation from PPP
Series A (2022): $25M led by 1315 Capital
Key Investors in Nutrisense
1315 Capital
1315 Capital is a healthcare-focused investment firm that specializes in commercial-stage healthcare companies, including healthcare services, pharma/medtech products, outsourcing, and health & wellness.
PPP
Public-Private Partnership
What's next for Nutrisense?
With the successful completion of this major enterprise-level funding, Nutrisense is expected to prioritize the scaling of its service infrastructure and the expansion of its user base. The strategic focus will likely shift toward enhancing the proprietary software ecosystem that supports its CGM sensors, potentially incorporating advanced predictive analytics to further personalize user health journeys. As the company matures, the integration of its metabolic data into broader healthcare networks remains a significant growth vector. By maintaining its commitment to clinical rigor and user-centric design, Nutrisense is well-positioned to capitalize on the burgeoning interest in metabolic health, setting the stage for future market leadership in the digital therapeutics space.
See full Nutrisense company page
